12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Methylprednisolone regulatory update

FDA and CDC identified bacteria contamination in lots of betamethasone and cardioplegia solution distributed by the compounding center. The agencies said the clinical significance of the results is not known. The agencies said the contamination reinforced FDA's concerns about the...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >